Ascendis Pharma A/SASND
Price (close)
$225.60
Market cap
$14.0B
P/E
—
Revenue (FY)
$720.1M
Net income
-$228.0M
Dividend yield
—
1-year total return
18.9%
Net margin
-31.7%
Revenue growth
98.0%
Debt / equity
—
What Ascendis Pharma A/S does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $7.0M | $7.8M | $51.2M | $266.7M | $363.6M | $720.1M |
| Net income | -$419.0M | -$383.6M | -$583.2M | -$481.4M | -$378.1M | -$228.0M |
| Free cash flow | -$291.4M | -$441.4M | -$510.2M | -$469.8M | — | — |
More on ASND.
- Ascendis Pharma A/S summary
- Ascendis Pharma A/S financial statements
- Ascendis Pharma A/S key metrics
- Ascendis Pharma A/S health scores and style box
- Ascendis Pharma A/S earnings
- Ascendis Pharma A/S dividends
- Ascendis Pharma A/S valuation
- Ascendis Pharma A/S ownership and insiders
- Ascendis Pharma A/S peers
Figures from Ascendis Pharma A/S's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.